Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
New study suggests that in hospital patients with T2DM, premixed insulin provides similar glycemic control as a basal-bolus insulin regimen.
Read More »Study Suggests Caution Needed When Using Premixed Insulin in the Hospital
AstraZeneca’s New Diabetes Drug Gets Delayed
The FDA is requiring the drug company to submit more clinical data.
Read More »Blood Type May Predict Diabetes Risk After Gestational Diabetes
Blood group also possible indicator of development of gestational diabetes itself.
Read More »The Influenza Vaccine Antibody Response in T2DM Patients
New research shows similar response in seniors with diabetes as those without.
Read More »Potential Benefit With Sensor-Augmented Insulin Pump Therapy
Findings suggest treatment may reduce urine albumin creatinine ratio in T1DM.
Read More »Management of Diabetes by Prescribing vs. Non-Prescribing Nurses
Findings show longer relationships and longer consultations between prescribing nurses and diabetic patients.
Read More »Fewer Adverse Effects Observed When Adding Dipeptidyl Peptidase-4 Inhibitors to Metformin Therapy
Combination does not alter myocardial infarction, hospitalization risks.
Read More »Dr. Larry Hirsch, Part 1: Efficacy of the Nano Needle in Obese Patients
Diabetes in Control publisher Steve Freed meets with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. Dr. Hirsch talks about the work toward improving patient experience when taking injections and the results of a study on the nano needle use in obese patients.
Read More »The Risk of Developing T2DM Increases with Melatonin at Mealtimes
People with the genetic variant MTNR1B may be at a greater risk.
Read More »Benefits Found in Duodenal-Jejunal Bypass Surgery
Improved metabolic function and induced moderate weight loss observed.
Read More »